Oncology

Your Article Summary

See Latest Articles

Recommendations on the use of 18F-FDG PET in oncology
The Journal of Nuclear Medicine, 03/12/08

Fletcher JW et al. - In a trial to develop recommendations on use of 18F-FDG PET in breast, colorectal, esophageal, head and neck, lung, pancreatic, and thyroid cancer; lymphoma, melanoma, and sarcoma; and unknown primary tumor, it was recommended that 18F-FDG PET should be used as an imaging tool in addition to conventional radiologic methods such as CT or MRI

• A search was performed to identify all published randomized controlled trials and systematic reviews in the literature
• An additional search was performed to identify relevant unpublished systematic reviews
• Publications comprised both retrospective and prospective studies of varied methodologic quality
• Anticipated consequences of false-positive and false-negative tests when evaluating clinical usefulness, and impact of 18F-FDG PET on management of cancer pts, were also reviewed

• 18F-FDG PET should be used as an imaging tool in addition to conventional radiologic methods such as CT or MRI
• Any positive finding that could lead to a clinically significant change in pt management should be confirmed by subsequent histopathologic examination because of the risk of false-positive results
• 18F-FDG PET should be used in the appropriate clinical setting for the diagnosis of head and neck, lung, or pancreatic cancer and for unknown primary tumor

Today in Breast...keeping you current

Receive free subspecialty "5-minute updates" via email

Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group
Journal of Clinical Oncology, 10/19/09

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
Annals of Oncology, 10/13/09

Pomegranate fruit extract impairs invasion and motility in human breast cancer
Integrative Cancer Therapies , 10/12/09

See All of Breast

Today in Colorectal Cancer/Polyps...keeping you current

Receive free subspecialty "5-minute updates" via email

Nonsteroidal anti-inflammatory drugs
Cancer, 10/16/09

Surgical management of colorectal liver metastases
Community Oncology , 10/09/09

Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09

See All of Colorectal Cancer/Polyps

Today in Diagnostics/Radiology...keeping you current

Receive free subspecialty "5-minute updates" via email

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09

Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09

See All of Diagnostics/Radiology

Today in GI Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma
New England Journal of Medicine, 10/22/09

Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer
Journal of Clinical Oncology, 11/02/09

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer
Journal of Clinical Oncology, 10/29/09

See All of GI Oncology

Today in Head and Neck...keeping you current

Receive free subspecialty "5-minute updates" via email

Mobile Phone Use and Risk of Tumors: A Meta-Analysis
Journal of Clinical Oncology, 10/20/09

Thyroid lymphoma and airway obstruction – is there a rationale for surgical management?
International Journal of Clinical Practice, 10/19/09

Primary extranodal marginal zone lymphoma of the uvea associated with massive diffuse epibulbar extension and focal infiltration of the optic nerve and meninges, clinically presented as uveitis masquerade syndrome: a case report
Medical Oncology, 10/16/09

See All of Head and Neck

Today in Hepatobiliary/Pancreas...keeping you current

Receive free subspecialty "5-minute updates" via email

Surgical management of colorectal liver metastases
Community Oncology , 10/09/09

Update and Review of the Multidisciplinary Management of Stage IV Colorectal Cancer with Liver Metastases
World Journal of Surgical Oncology, 10/02/09

Novel agents for the treatment of adenocarcinoma of the pancreas
Expert Review of Anticancer Therapy, 10/22/09

See All of Hepatobiliary/Pancreas

Today in Leukemia/Lymphoma...keeping you current

Receive free subspecialty "5-minute updates" via email

Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry.
Annals of Rheumatic Diseases, 10/22/09

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the childrens oncology group
Journal of Clinical Oncology, 10/12/09

Primary extranodal marginal zone lymphoma of the uvea associated with massive diffuse epibulbar extension and focal infiltration of the optic nerve and meninges, clinically presented as uveitis masquerade syndrome: a case report
Medical Oncology, 10/16/09

See All of Leukemia/Lymphoma

Today in Lung/Thoracic Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09

Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer
Annals of Oncology, 10/19/09

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase III study
The Lancet, 10/26/09

See All of Lung/Thoracic Oncology

Today in Soft Tissue/Sarcoma...keeping you current

Receive free subspecialty "5-minute updates" via email

Adjuvant Chemotherapy in Localized Soft Tissue Sarcomas: Still Not Proven
The Oncologist, 10/28/09

Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review
Annals of Oncology, 10/30/09

Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy
Annals of Oncology, 11/04/09

See All of Soft Tissue/Sarcoma